Switching to biosimilar infliximab: real world data in patients with severe inflammatory arthritis.
Clin Exp Rheumatol
; 36(1): 171-172, 2018.
Article
in En
| MEDLINE
| ID: mdl-29352847
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis
/
Biological Products
/
Antirheumatic Agents
/
Drug Substitution
/
Biosimilar Pharmaceuticals
/
Infliximab
Type of study:
Diagnostic_studies
/
Observational_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Exp Rheumatol
Year:
2018
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
Italy